MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
MEDIFAST INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$12.03+0.15 (+1.26%)
Close on Oct 19, 2026
- Market cap
- $133.95M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Share price
−$0.89 (−6.89%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
MEDIFAST INC saw revenue fall 34.0% to $316.93M over the twelve months to Jun 30, 2026. Operating income fell 4105.3% to -$19.51M, moving the operating margin from 0.1% to -6.2%. Free cash flow was $4.01M.
Revenue
$316.93M
-34.0% vs. a year earlier
Operating income
-$19.51M
-4105.3% vs. a year earlier
Free cash flow
$4.01M
TTM Q2 2026
EPS, diluted
-$2.33
-828.1% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $133.95M
- P/E ratio
- –
- Price to sales
- 0.42
- Price to book
- 0.68
- Dividend yield
- 0.00%
- Free cash flow yield
- 3.00%
Fundamentals
- Revenue
- $316.93M
- Net income
- -$25.60M
- EPS, diluted
- -$2.33
- Free cash flow
- $4.01M
- Book value per share
- $17.64
- Diluted shares
- 11M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$316.93M-34.0% YoY
Gross profit
$219.45M-38.1% YoY
Operating income
-$19.51M-4105.3% YoY
Net income
-$25.60M-803.7% YoY
EPS, diluted
-$2.33-828.1% YoY
Free cash flow
$4.01M
Reported periodTrailing twelve months